Niva Bupa Health Insurance Company Limited was barred by the Insurance Regulatory and Development Authority of India from opening new branches for six months after breaching expenses of management limits in FY25 for the second consecutive year. Irdai denied the insurer's forbearance request despite the General Insurance Council recommending leniency, though Niva Bupa had been granted forbearance in FY24. Niva Bupa cited expansion, technology and brand transition costs and told exchanges on 20 August that it was within EoM limits in FY26 and the first quarter of FY27.

Niva Bupa Health Insurance Company Limited said ICRA reaffirmed its issuer rating at [ICRA]AAA (Stable) and assigned [ICRA]AA+ (Stable) to proposed subordinated debt of up to Rs 500 crore via listed, rated, unsecured, subordinated, redeemable non-convertible debentures.